Publication | Closed Access

Term planned delivery based on fetal growth assessment with or without the cerebroplacental ratio in low-risk pregnancies (RATIO37): an international, multicentre, open-label, randomised controlled trial

FertilityFetal MedicinePediatricsGynecologyPregnancyMaternal HealthCerebroplacental RatioFetal Growth AssessmentObstetricsPrematurityMaternal-fetal MedicineLow-risk PregnanciesPublic HealthPreterm BirthMedicine